These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38857863)

  • 1. Next generation risk assessment for occupational chemical safety - A real world example with sodium-2-hydroxyethane sulfonate.
    Wood A; Breffa C; Chaine C; Cubberley R; Dent M; Eichhorn J; Fayyaz S; Grimm FA; Houghton J; Kiwamoto R; Kukic P; Lee M; Malcomber S; Martin S; Nicol B; Reynolds J; Riley G; Scott S; Smith C; Westmoreland C; Wieland W; Williams M; Wolton K; Zellmann T; Gutsell S
    Toxicology; 2024 Aug; 506():153835. PubMed ID: 38857863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation risk assessment: an
    Ebmeyer J; Najjar A; Lange D; Boettcher M; Voß S; Brandmair K; Meinhardt J; Kuehnl J; Hewitt NJ; Krueger CT; Schepky A
    Front Pharmacol; 2024; 15():1345992. PubMed ID: 38515841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.
    Moxon TE; Li H; Lee MY; Piechota P; Nicol B; Pickles J; Pendlington R; Sorrell I; Baltazar MT
    Toxicol In Vitro; 2020 Mar; 63():104746. PubMed ID: 31837441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products.
    Baltazar MT; Cable S; Carmichael PL; Cubberley R; Cull T; Delagrange M; Dent MP; Hatherell S; Houghton J; Kukic P; Li H; Lee MY; Malcomber S; Middleton AM; Moxon TE; Nathanail AV; Nicol B; Pendlington R; Reynolds G; Reynolds J; White A; Westmoreland C
    Toxicol Sci; 2020 Jul; 176(1):236-252. PubMed ID: 32275751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow.
    Middleton AM; Reynolds J; Cable S; Baltazar MT; Li H; Bevan S; Carmichael PL; Dent MP; Hatherell S; Houghton J; Kukic P; Liddell M; Malcomber S; Nicol B; Park B; Patel H; Scott S; Sparham C; Walker P; White A
    Toxicol Sci; 2022 Aug; 189(1):124-147. PubMed ID: 35822611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerations.
    Li H; Yuan H; Middleton A; Li J; Nicol B; Carmichael P; Guo J; Peng S; Zhang Q
    Toxicol In Vitro; 2021 Aug; 74():105171. PubMed ID: 33848589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment.
    Kunnen SJ; Arnesdotter E; Willenbockel CT; Vinken M; van de Water B
    ALTEX; 2024; 41(2):213-232. PubMed ID: 38376873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next Generation Risk Assessment of the Anti-Androgen Flutamide Including the Contribution of Its Active Metabolite Hydroxyflutamide.
    van Tongeren TCA; Carmichael PL; Rietjens IMCM; Li H
    Front Toxicol; 2022; 4():881235. PubMed ID: 35722059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine.
    Bury D; Alexander-White C; Clewell HJ; Cronin M; Desprez B; Detroyer A; Efremenko A; Firman J; Hack E; Hewitt NJ; Kenna G; Klaric M; Lester C; Mahony C; Ouedraogo G; Paini A; Schepky A;
    Regul Toxicol Pharmacol; 2021 Jul; 123():104931. PubMed ID: 33905778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
    Alexander-White C; Bury D; Cronin M; Dent M; Hack E; Hewitt NJ; Kenna G; Naciff J; Ouedraogo G; Schepky A; Mahony C; Europe C
    Regul Toxicol Pharmacol; 2022 Mar; 129():105094. PubMed ID: 34990780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment.
    Reale E; Zare Jeddi M; Paini A; Connolly A; Duca R; Cubadda F; Benfenati E; Bessems J; S Galea K; Dirven H; Santonen T; M Koch H; Jones K; Sams C; Viegas S; Kyriaki M; Campisi L; David A; Antignac JP; B Hopf N
    Environ Int; 2024 Feb; 184():108474. PubMed ID: 38350256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - A case study with parabens.
    Ouedraogo G; Alexander-White C; Bury D; Clewell HJ; Cronin M; Cull T; Dent M; Desprez B; Detroyer A; Ellison C; Giammanco S; Hack E; Hewitt NJ; Kenna G; Klaric M; Kreiling R; Lester C; Mahony C; Mombelli E; Naciff J; O'Brien J; Schepky A; Tozer S; van der Burg B; van Vugt-Lussenburg B; Stuard S; Cosmetics Europe
    Regul Toxicol Pharmacol; 2022 Jul; 132():105161. PubMed ID: 35508214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A framework for chemical safety assessment incorporating new approach methodologies within REACH.
    Ball N; Bars R; Botham PA; Cuciureanu A; Cronin MTD; Doe JE; Dudzina T; Gant TW; Leist M; van Ravenzwaay B
    Arch Toxicol; 2022 Mar; 96(3):743-766. PubMed ID: 35103819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ready for regulatory use: NAMs and NGRA for chemical safety assurance.
    Carmichael PL; Baltazar MT; Cable S; Cochrane S; Dent M; Li H; Middleton A; Muller I; Reynolds G; Westmoreland C; White A
    ALTEX; 2022; 39(3):359–366. PubMed ID: 35796331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBK modelling of topical application and characterisation of the uncertainty of C
    Li H; Reynolds J; Sorrell I; Sheffield D; Pendlington R; Cubberley R; Nicol B
    Toxicol Appl Pharmacol; 2022 May; 442():115992. PubMed ID: 35346730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation risk assessment for skin allergy: Decision making using new approach methodologies.
    Gilmour N; Reynolds J; Przybylak K; Aleksic M; Aptula N; Baltazar MT; Cubberley R; Rajagopal R; Reynolds G; Spriggs S; Thorpe C; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Jun; 131():105159. PubMed ID: 35311660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A workflow to practically apply true dose considerations to in vitro testing for next generation risk assessment.
    Nicol B; Vandenbossche-Goddard E; Thorpe C; Newman R; Patel H; Yates D
    Toxicology; 2024 Jun; 505():153826. PubMed ID: 38719068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans.
    Geci R; Gadaleta D; de Lomana MG; Ortega-Vallbona R; Colombo E; Serrano-Candelas E; Paini A; Kuepfer L; Schaller S
    Arch Toxicol; 2024 May; ():. PubMed ID: 38722347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying and Characterizing Stress Pathways of Concern for Consumer Safety in Next-Generation Risk Assessment.
    Hatherell S; Baltazar MT; Reynolds J; Carmichael PL; Dent M; Li H; Ryder S; White A; Walker P; Middleton AM
    Toxicol Sci; 2020 Jul; 176(1):11-33. PubMed ID: 32374857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.